06/11/2021
DAWAI EXPERT COMMUNICATION π
The FDA issued an emergency use authorization (EUA) for the iHealth COVID-19 Antigen Rapid Test, an OTC COVID-19 antigen diagnostic test that delivers results in 15 minutes π’
The test can be used as βοΈ
β
A single test for people with COVID-19 symptoms.
β
A serial test for people without symptoms, meaning the test is done two times over three days.
The test can be used for peopleβοΈ
β
Age 15 years or older with a self-collected nasal swab sample.
β
Age 2 years or older when an adult collects the nasal swab sample.
FDA Authorizes Another OTC COVID-19 Test U.S. Food and Drug Administration sent this bulletin at 11/05/2021 01:48 PM EDT If your email program has trouble displaying this email, view as a webpage. FDA Authorizes Another COVID-19 Over-the-Counter Test The U.S. Food and Drug Administration (FDA) autho...